5
views
0
recommends
+1 Recommend
3 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Commentary: Measuring excess mortality due to the COVID-19 pandemic: progress and persistent challenges

      research-article
      1 , , 2
      International Journal of Epidemiology
      Oxford University Press

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Since the beginning of the COVID-19 pandemic, health authorities worldwide periodically report COVID-19 cases and deaths. These ‘official’ counts are aggregated primarily from data compiled by laboratories and hospitals, 1 and they document, imperfectly, the effects of COVID-19 on population health. 2–4 Case counts are partial due to limited testing 5 and death counts might miss COVID deaths that occur outside of health facilities. 6 These figures also exclude non-COVID deaths which are indirectly a result of the pandemic (e.g. because of disrupted health services). 7 The total effects of the pandemic are more reliably captured by the concept of ‘excess mortality’. This is the difference between the number of deaths (from any cause) that occur during the pandemic and the number of deaths that would have occurred in the absence of the pandemic. Many analysts consider excess mortality as ‘the most objective possible indicator of the COVID-19 death toll’. 8 Four recent papers in the International Journal of Epidemiology used this counterfactual approach to paint a nuanced picture of the impact of COVID-19. 9–12 In 2020, countries like Japan 12 and Denmark 10 experienced lower than expected mortality, whereas deaths have increased substantially in the USA, UK and other countries. 9–11 Excess mortality has affected older adults disproportionately, but increases in mortality among people of working age were observed in the USA and elsewhere. 9 Gender differences in excess mortality have varied across countries. Excess deaths were also concentrated in socioeconomically disadvantaged groups. 11 Data from systems that continuously record all deaths, irrespective of their cause(s), testing status and the place where they occurred, are essential in investigations of excess mortality. The four recent International Journal of Epidemiology papers relied on civil registration—the administrative systems that aim to record all vital events. In Ecuador, excess deaths estimated from civil registration data were five times larger than the number of reported COVID-19 deaths. 11 Similar discrepancies between excess mortality estimates and official counts of COVID-19 deaths have been documented elsewhere. 13 Measuring excess mortality requires comparing weekly or monthly counts of deaths with the expected number of deaths in that same week or month. In some studies, this baseline value is computed as the average number of deaths in pre-pandemic years (e.g. 2015–19). 10 , 11 More refined models also account for the seasonality of deaths 10 and long-term trends in population size and mortality, 14 as well as other potential confounders. Onozuka et al. thus controlled for weather patterns and influenza activity that might have prompted short-term mortality fluctuations in Japan, independently of the COVID-19 pandemic. 12 Several research groups have used an ensemble approach that combines estimates from a large number of statistical models with different covariates and specifications. 15 , 16 International comparisons of excess mortality might be complicated by cross-country differences in population characteristics. Analysts frequently use P-scores (i.e. the percentage by which observed deaths exceed expected deaths) to account for differences in baseline mortality. 14 Aburto and colleagues also elegantly controlled for differences in population age structures. 9 They translated age patterns of excess mortality into changes in life expectancy at birth—the average lifespan a fictitious cohort would achieve if its members experienced the age-specific death rates in a given year through their entire (hypothetical) life course. Using this metric, they compared the magnitude of mortality shocks prompted by COVID-19 between disparate countries, and across historical periods. Analyses of excess mortality have great potential to help understand what works in mitigating the effects of health crises. In Ecuador, public health and social measures (e.g. social distancing) preceded sharp declines in excess mortality. 11 By comparison, these interventions were weakly associated with trends in official counts of COVID-19 deaths, possibly because increased testing led to improved case detection. Achilleos et al. found high excess mortality in countries that delayed COVID-19 control measures. 10 Conversely, countries with lower than expected mortality might provide lessons in COVID-19 control and in the prevention of conditions indirectly affected by the pandemic (e.g. respiratory diseases such as influenza). Data limitations might affect excess mortality measures. Some deaths are only registered after delays, prompting repeated updates of excess mortality figures. Civil registration systems also miss some vital events. 17 In high-income countries, unrecorded deaths are few and do not affect most estimates. Elsewhere, this issue is more pervasive. In Ecuador, for example, only two-thirds of deaths might be registered. 18 Analysts often assume that excess mortality estimates are accurate despite such data gaps if the completeness of death registration stays constant over time. 11 This reasoning only applies to the ratio of recorded to expected mortality, not to the number of excess deaths. If civil registers are incomplete, the true number of excess deaths will be larger than observed by a factor equal to the inverse of the proportion of registered deaths. Accurate excess mortality estimates require careful assessments of the completeness of civil registration. 19 , 20 Data challenges are compounded when the completeness of registration varies between groups and/or over time. In Ecuador, death registration rates prior to COVID-19 varied from less than 30% to more than 90% across provinces. 18 During the pandemic, some countries suspended registration services for extended periods. 21 Where registration continued, 22 mobility restrictions and fear of infection might have prevented visits to registration offices. Yet in other places, registration rates might have recently increased due to new reporting systems or greater public attention on death reporting. 23 In many settings, fluctuations in the number of recorded deaths might thus reflect changes in the completeness of death registration, as well as excess mortality. In some cases, drops in registration rates might even hide the occurrence of excess deaths. Several methods exist to adjust incomplete civil registration data. Unfortunately, commonly used death-distribution methods 24 require data that may not have been collected recently in many countries (e.g. census data). They also make unrealistic assumptions about migration and other recent population dynamics. The recent Adair-Lopez method uses more widely available data inputs, and relaxes several implausible assumptions. 25 However, this method relies largely on child mortality estimates to infer the completeness of death registration. Its assumptions might thus be less robust during a pandemic like COVID-19 that disproportionately affects mortality among older people. Sensitivity analyses and robustness tests should accompany estimates of excess mortality obtained from incomplete death records. Some high-income and upper-middle-income countries are now accelerating the release of provisional data on all-cause mortality, 26 but data on excess mortality are lacking for large parts of the world. Among 39 countries investigated in the recent International Journal of Epidemiology papers, 2–4 more than 30 were in Europe versus four in Latin America, one in Africa and none in the Middle East or South Asia. Similar gaps exist in comprehensive excess mortality databases 8 , 27 because civil registration systems in many low- and lower-middle-income countries (LLMICs) are too incomplete to produce vital statistics. 17 Instead, outdated snapshots of mortality in LLMICs are obtained every few years, when retrospective data are collected during household surveys or decennial censuses. This constrains the ability of LLMICs to document how health crises affect their populations and might sustain beliefs that they have been ‘spared’ by the COVID-19 pandemic, and thus require fewer resources (e.g. vaccines) than wealthier countries. 28 Improving the recording of deaths in civil registration systems is one of the indicators of progress towards the sustainable development goals. Obstacles to death registration in LLMICs include, for example, inadequate legal frameworks, insufficient operating budgets, difficulties in accessing registration offices, imperfect coordination between governmental agencies, and limited knowledge about death registration among families. 17 Recently, interventions that engage health workers and other community-based agents and equip them with improved digital tools have been successful in rapidly increasing death reporting in several LLMIC communities. 29 Policies that jointly promote the availability of registration services and awareness about civil registration might also be well suited to further accelerating progress towards universal death registration. 30 Future global pandemic preparedness plans should include large investments to support and expand similar efforts to strengthen civil registration systems in LLMICs. 21 , 28 Funding This work was supported by grants from the US National Institute of Aging (R03AG070660), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD088516) and the Brazilian National Council for Scientific and Technological Development (CNPq 303341/2018-1). Author contributions S.H. and B.L.Q. conceived of the paper, drafted and subsequently revised the text. Both authors approved the final version. Conflict of interest None declared.

          Related collections

          Most cited references33

          • Record: found
          • Abstract: found
          • Article: not found

          An interactive web-based dashboard to track COVID-19 in real time

          In December, 2019, a local outbreak of pneumonia of initially unknown cause was detected in Wuhan (Hubei, China), and was quickly determined to be caused by a novel coronavirus, 1 namely severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The outbreak has since spread to every province of mainland China as well as 27 other countries and regions, with more than 70 000 confirmed cases as of Feb 17, 2020. 2 In response to this ongoing public health emergency, we developed an online interactive dashboard, hosted by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University, Baltimore, MD, USA, to visualise and track reported cases of coronavirus disease 2019 (COVID-19) in real time. The dashboard, first shared publicly on Jan 22, illustrates the location and number of confirmed COVID-19 cases, deaths, and recoveries for all affected countries. It was developed to provide researchers, public health authorities, and the general public with a user-friendly tool to track the outbreak as it unfolds. All data collected and displayed are made freely available, initially through Google Sheets and now through a GitHub repository, along with the feature layers of the dashboard, which are now included in the Esri Living Atlas. The dashboard reports cases at the province level in China; at the city level in the USA, Australia, and Canada; and at the country level otherwise. During Jan 22–31, all data collection and processing were done manually, and updates were typically done twice a day, morning and night (US Eastern Time). As the outbreak evolved, the manual reporting process became unsustainable; therefore, on Feb 1, we adopted a semi-automated living data stream strategy. Our primary data source is DXY, an online platform run by members of the Chinese medical community, which aggregates local media and government reports to provide cumulative totals of COVID-19 cases in near real time at the province level in China and at the country level otherwise. Every 15 min, the cumulative case counts are updated from DXY for all provinces in China and for other affected countries and regions. For countries and regions outside mainland China (including Hong Kong, Macau, and Taiwan), we found DXY cumulative case counts to frequently lag behind other sources; we therefore manually update these case numbers throughout the day when new cases are identified. To identify new cases, we monitor various Twitter feeds, online news services, and direct communication sent through the dashboard. Before manually updating the dashboard, we confirm the case numbers with regional and local health departments, including the respective centres for disease control and prevention (CDC) of China, Taiwan, and Europe, the Hong Kong Department of Health, the Macau Government, and WHO, as well as city-level and state-level health authorities. For city-level case reports in the USA, Australia, and Canada, which we began reporting on Feb 1, we rely on the US CDC, the government of Canada, the Australian Government Department of Health, and various state or territory health authorities. All manual updates (for countries and regions outside mainland China) are coordinated by a team at Johns Hopkins University. The case data reported on the dashboard aligns with the daily Chinese CDC 3 and WHO situation reports 2 for within and outside of mainland China, respectively (figure ). Furthermore, the dashboard is particularly effective at capturing the timing of the first reported case of COVID-19 in new countries or regions (appendix). With the exception of Australia, Hong Kong, and Italy, the CSSE at Johns Hopkins University has reported newly infected countries ahead of WHO, with Hong Kong and Italy reported within hours of the corresponding WHO situation report. Figure Comparison of COVID-19 case reporting from different sources Daily cumulative case numbers (starting Jan 22, 2020) reported by the Johns Hopkins University Center for Systems Science and Engineering (CSSE), WHO situation reports, and the Chinese Center for Disease Control and Prevention (Chinese CDC) for within (A) and outside (B) mainland China. Given the popularity and impact of the dashboard to date, we plan to continue hosting and managing the tool throughout the entirety of the COVID-19 outbreak and to build out its capabilities to establish a standing tool to monitor and report on future outbreaks. We believe our efforts are crucial to help inform modelling efforts and control measures during the earliest stages of the outbreak.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset

            Comparing the impact of the COVID-19 pandemic between countries or across time is difficult because the reported numbers of cases and deaths can be strongly affected by testing capacity and reporting policy. Excess mortality, defined as the increase in all-cause mortality relative to the expected mortality, is widely considered as a more objective indicator of the COVID-19 death toll. However, there has been no global, frequently updated repository of the all-cause mortality data across countries. To fill this gap, we have collected weekly, monthly, or quarterly all-cause mortality data from 103 countries and territories, openly available as the regularly updated World Mortality Dataset. We used this dataset to compute the excess mortality in each country during the COVID-19 pandemic. We found that in several worst-affected countries (Peru, Ecuador, Bolivia, Mexico) the excess mortality was above 50% of the expected annual mortality (Peru, Ecuador, Bolivia, Mexico) or above 400 excess deaths per 100,000 population (Peru, Bulgaria, North Macedonia, Serbia). At the same time, in several other countries (e.g. Australia and New Zealand) mortality during the pandemic was below the usual level, presumably due to social distancing measures decreasing the non-COVID infectious mortality. Furthermore, we found that while many countries have been reporting the COVID-19 deaths very accurately, some countries have been substantially underreporting their COVID-19 deaths (e.g. Nicaragua, Russia, Uzbekistan), by up to two orders of magnitude (Tajikistan). Our results highlight the importance of open and rapid all-cause mortality reporting for pandemic monitoring. Countries around the world reported 4.2 million deaths from SARS-CoV-2 (the virus that causes COVID-19) from the beginning of pandemic until the end of July 2021, but the actual number of deaths is likely higher. While some countries may have imperfect systems for counting deaths, others may have intentionally underreported them. To get a better estimate of deaths from an event such as a pandemic, scientists often compare the total number of deaths in a country during the event to the expected number of deaths based on data from previous years. This tells them how many excess deaths occurred during the event. To provide a more accurate count of deaths caused by COVID-19, Karlinsky and Kobak built a database called the World Mortality Dataset. It includes information on deaths from all causes from 103 countries. Karlinsky and Kobak used the database to compare the number of reported COVID-19 deaths reported to the excess deaths from all causes during the pandemic. Some of the hardest hit countries, including Peru, Ecuador, Bolivia, and Mexico, experienced over 50% more deaths than expected during the pandemic. Meanwhile, other countries like Australia and New Zealand, reported fewer deaths than normal. This is likely because social distancing measures reduced deaths from infections like influenza. Many countries reported their COVID-19 deaths accurately, but Karlinsky and Kobak argue that other countries, including Nicaragua, Russia, and Uzbekistan, underreported COVID-19 deaths. Using their database, Karlinsky and Kobak estimate that, in those countries, there have been at least 1.4 times more deaths due to COVID-19 than reported – adding over 1 million extra deaths in total. But they note that the actual number is likely much higher because data from more than 100 countries were not available to include in the database. The World Mortality Dataset provides a more accurate picture of the number of people who died because of the COVID-19 pandemic, and it is available online and updated daily. The database may help scientists develop better mitigation strategies for this pandemic or future ones.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries

              The Coronavirus Disease 2019 (COVID-19) pandemic has changed many social, economic, environmental and healthcare determinants of health. We applied an ensemble of 16 Bayesian models to vital statistics data to estimate the all-cause mortality effect of the pandemic for 21 industrialized countries. From mid-February through May 2020, 206,000 (95% credible interval, 178,100-231,000) more people died in these countries than would have had the pandemic not occurred. The number of excess deaths, excess deaths per 100,000 people and relative increase in deaths were similar between men and women in most countries. England and Wales and Spain experienced the largest effect: ~100 excess deaths per 100,000 people, equivalent to a 37% (30-44%) relative increase in England and Wales and 38% (31-45%) in Spain. Bulgaria, New Zealand, Slovakia, Australia, Czechia, Hungary, Poland, Norway, Denmark and Finland experienced mortality changes that ranged from possible small declines to increases of 5% or less in either sex. The heterogeneous mortality effects of the COVID-19 pandemic reflect differences in how well countries have managed the pandemic and the resilience and preparedness of the health and social care system.
                Bookmark

                Author and article information

                Journal
                Int J Epidemiol
                Int J Epidemiol
                ije
                International Journal of Epidemiology
                Oxford University Press
                0300-5771
                1464-3685
                February 2022
                14 December 2021
                14 December 2021
                : 51
                : 1
                : 85-87
                Affiliations
                [1 ] New York University—Abu Dhabi Campus , Division of Social Science, Program in Social Research and Public Policy, Abu Dhabi, United Arab Emirates and
                [2 ] Universidade Federal de Minas Gerais , Department of Demography and Centro de Desenvolvimento e Planejamento Regional (CEDEPLAR), Belo Horizonte, Minas Gerais, Brazil
                Author notes
                Corresponding author. New York University—Abu Dhabi Campus, Social Science Building (A5), Saadiyat Campus, PO Box 129188, Abu Dhabi, United Arab Emirates United Arab Emirates. E-mail: sh199@ 123456nyu.edu
                Article
                dyab260
                10.1093/ije/dyab260
                8856005
                34904168
                5186fd87-f13f-4b5f-8bb4-0e65e51bc997
                © The Author(s) 2021; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association

                This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)

                This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

                History
                : 15 October 2021
                : 30 November 2021
                Page count
                Pages: 3
                Funding
                Funded by: US National Institute of Aging;
                Award ID: R03AG070660
                Funded by: Eunice Kennedy Shriver National Institute of Child Health and Human Development, DOI 10.13039/100009633;
                Award ID: R01HD088516
                Funded by: Brazilian National Council for Scientific and Technological Development;
                Award ID: CNPq 303341/2018-1
                Categories
                Covid-19
                AcademicSubjects/MED00860

                Public health
                Public health

                Comments

                Comment on this article